What other conditions are associated with an increased risk of SIBO?

    Researchedby:
    Last Updated: October 25, 2023

    Although SIBO hasn’t been identified as a definitive cause or consequence of any other disease, it is associated with a number of conditions that create an abnormal intestinal environment, which could include:

    • A less acidic (more hospitable) small intestine
    • Slower (more accessible) transit of food through the GI tract
    • Abnormal muscular contractions that push contents (and microbes) backward, from the large to the small intestine
    • Reduced immune activity that would normally regulate microbial growth

    It is thought that these factors create a nutrient-rich environment that lacks the normal mechanisms for controlling microbial growth, and SIBO develops as a result.[1][2]

    Functional dyspepsia (commonly known as indigestion), IBS, IBD, diabetes (types 1 and 2), dysregulated gut motility (food moving more slowly through the intestines due to abnormal muscular contractions), chronic pancreatitis, chronic liver disease, Parkinson’s disease, and systemic sclerosis (an autoimmune disorder) are all associated with greater odds of a positive SIBO diagnosis. Limited evidence also suggests that females with IBS may be more likely to have SIBO compared with males who have IBS.[3][4][1][5][6][7][2][8][9][10]

    A history of GI surgery (such as gastric bypass or resectioning of the intestines), the use of acid-reducing proton-pump inhibitors (PPIs), and smoking are also associated with a greater likelihood of having SIBO.[5][1][11]

    Though celiac disease isn’t linked to an increased chance of having SIBO, one analysis observed higher rates of SIBO in people with celiac disease who were unresponsive to a gluten-free diet compared with healthy controls. However, most of the analyses detected inconsistencies and issues with the quality of studies used to determine the prevalence of SIBO in these conditions.[12]

    References

    1. ^Ayesha Shah, Mark Morrison, Daniel Burger, Neal Martin, Justin Rich, Mike Jones, Natasha Koloski, Marjorie M Walker, Nicholas J Talley, Gerald J HoltmannSystematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel diseaseAliment Pharmacol Ther.(2019 Mar)
    2. ^Xin Feng, Xiao-Qing Li, Zheng JiangPrevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysisClin Rheumatol.(2021 Aug)
    3. ^Saravana Ruban Gurusamy, Ayesha Shah, Nicholas J Talley, Natasha Koloski, Michael P Jones, Marjorie M Walker, Mark Morrison, Gerald HoltmannSmall Intestinal Bacterial Overgrowth in Functional Dyspepsia: A Systematic Review and Meta-AnalysisAm J Gastroenterol.(2021 May 1)
    4. ^Binrui Chen, John Jae-Woo Kim, Yawen Zhang, Lijun Du, Ning DaiPrevalence and predictors of small intestinal bacterial overgrowth in irritable bowel syndrome: a systematic review and meta-analysisJ Gastroenterol.(2018 Jul)
    5. ^Jean-Marc Sabate, Muriel Coupaye, Séverine Ledoux, Benjamin Castel, Simon Msika, Benoit Coffin, Pauline JouetConsequences of Small Intestinal Bacterial Overgrowth in Obese Patients Before and After Bariatric SurgeryObes Surg.(2017 Mar)
    6. ^Ayesha Shah, Erin Shanahan, Graeme A Macdonald, Linda Fletcher, Pegah Ghasemi, Mark Morrison, Mike Jones, Gerald HoltmannSystematic Review and Meta-Analysis: Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Liver DiseaseSemin Liver Dis.(2017 Nov)
    7. ^Bara El Kurdi, Sumbal Babar, Mahmoud El Iskandarani, Adam Bataineh, Markus M Lerch, Mark Young, Vijay P SinghFactors That Affect Prevalence of Small Intestinal Bacterial Overgrowth in Chronic Pancreatitis: A Systematic Review, Meta-Analysis, and Meta-RegressionClin Transl Gastroenterol.(2019 Sep)
    8. ^Karn Wijarnpreecha, Susan Lou, Kanramon Watthanasuntorn, Paul T Kroner, Wisit Cheungpasitporn, Frank J Lukens, Surakit Pungpapong, Andrew P Keaveny, Patompong UngprasertSmall intestinal bacterial overgrowth and nonalcoholic fatty liver disease: a systematic review and meta-analysisEur J Gastroenterol Hepatol.(2020 May)
    9. ^Roman Maslennikov, Chavdar Pavlov, Vladimir IvashkinSmall intestinal bacterial overgrowth in cirrhosis: systematic review and meta-analysisHepatol Int.(2018 Nov)
    10. ^C Jacobs, E Coss Adame, A Attaluri, J Valestin, S S C RaoDysmotility and proton pump inhibitor use are independent risk factors for small intestinal bacterial and/or fungal overgrowthAliment Pharmacol Ther.(2013 Jun)
    11. ^Tingting Su, Sanchuan Lai, Allen Lee, Xingkang He, Shujie ChenMeta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowthJ Gastroenterol.(2018 Jan)
    12. ^Mohammad-Ayman A Safi, Asif A Jiman-Fatani, Omar I SaadahSmall intestinal bacterial overgrowth among patients with celiac disease unresponsive to a gluten free dietTurk J Gastroenterol.(2020 Nov)